Inventor · disambiguated record
Louis Nickolaus Jungheim
Also filed as: JUNGHEIM LOUIS N · JUNGHEIM LOUIS NICKOLAUS
29 granted patents·2 pending applications·455 citations·filing 1985–2013
96Inventor score
Top patents by PatentIndex Score
31 records- 0196US5891874AAnti-viral compoundLILLY CO ELI·Filed 1997·Granted Apr 6, 1999·163 cites·12 claims
- 0286US7179804B2Tachykinin receptor antagonistsLILLY CO ELI·Filed 2003·Granted Feb 20, 2007·30 cites·18 claims
- 0385US7320994B2Triazole derivatives as tachykinin receptor antagonistsLILLY CO ELI·Filed 2003·Granted Jan 22, 2008·28 cites·34 claims
- 0484US5905077AInhibitors of HIV protease useful for the treatment of AIDSLILLY CO ELI·Filed 1997·Granted May 18, 1999·65 cites·27 claims
- 0578US7947841B2Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (GLP)-1 compound or a melanocortin-4 receptor (MC4) agonist peptideEMISPHERE TECH INC·Filed 2008·Granted May 24, 2011·2 cites·15 claims
- 0678US7662771B2Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (GLP)-1 compound or a melanocortin-4 receptor (MC4) agonist peptideEMISPHERE TECH INC·Filed 2004·Granted Feb 16, 2010·7 cites·10 claims
- 0778US5502061APeptidyl substituted benzamides and naphthamiesLILLY CO ELI·Filed 1994·Granted Mar 26, 1996·60 cites·32 claims
- 0877US5733906AInhibitors of HIV Protease useful for the treatment of AidsLILLY CO ELI·Filed 1993·Granted Mar 31, 1998·17 cites·14 claims
- 0971US6743794B2Methods and compounds for inhibiting MRP1LILLY CO ELI·Filed 2000·Granted Jun 1, 2004·7 cites·39 claims
- 1068US8546581B2Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (Glp)-1 compound or a melanocortin-4 receptor (Mc4) agonist peptideJUNGHEIM LOUIS NICKOLAUS·Filed 2011·Granted Oct 1, 2013·1 cites·13 claims
- 1168US5554653AInhibitors of HIV protease useful for the treatment of AIDSLILLY CO ELI·Filed 1992·Granted Sep 10, 1996·10 cites·28 claims
- 1267US8765796B2Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (GLP-1) compound or a melanocortin-4 receptor (MC4) agonist peptideEMISPHERE TECH INC·Filed 2013·Granted Jul 1, 2014·0 cites·12 claims
- 1367US8552039B2Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (GLP-1) compound or a melanocortin-4 receptor (MC4) agonist peptideHERR ROBERT JASON·Filed 2009·Granted Oct 8, 2013·1 cites·14 claims
- 1466US5821242AAnti-viral compoundsLILLY CO ELI·Filed 1997·Granted Oct 13, 1998·12 cites·14 claims
- 1560US4767871APyrazolidinium ylidesLILLY CO ELI·Filed 1987·Granted Aug 30, 1988·5 cites·17 claims
- 1659US6992097B2Growth hormone secretagoguesLILLY CO ELI·Filed 2003·Granted Jan 31, 2006·1 cites·15 claims
- 1757US6114327AAnti-viral compoundsLILLY CO ELI·Filed 1999·Granted Sep 5, 2000·9 cites·20 claims
- 1857US5011938A7-substituted bicyclic pyrazolidinonesLILLY CO ELI·Filed 1990·Granted Apr 30, 1991·6 cites·10 claims
- 1956US6653281B1Ring modified cyclic peptide analogsLILLY CO ELI·Filed 1999·Granted Nov 25, 2003·16 cites·20 claims
- 2055US2007293423A1Compounds, Methods and Formulations for the Oral Delivery of a Glucagon-Like Peptide (Glp)-1 Compound or a Melanocortin-4 Receptor (Mc4) Agonist PeptideLILLY CO ELI·Filed 2004·Application pending·0 cites
- 2154US6271235B1HIV protease inhibitorsAGOURON PHARMA·Filed 1995·Granted Aug 7, 2001·5 cites·18 claims
- 2250US6939946B2Ring modified cyclic peptide analogsLILLY CO ELI·Filed 2003·Granted Sep 6, 2005·0 cites·18 claims
- 2348US4902707ABicyclic pyrazolidinones, compositions and useLILLY CO ELI·Filed 1985·Granted Feb 20, 1990·5 cites·19 claims
- 2445US5461154AIntermediate and process for makingLILLY CO ELI·Filed 1994·Granted Oct 24, 1995·2 cites·1 claims
- 2544US4940718A7-substituted bicyclic pyrazolidinones, pharmaceutical compositions and useLILLY CO ELI·Filed 1989·Granted Jul 10, 1990·2 cites·26 claims
- 2644US2006160794A1Tachykinin receptor antagonistsAMEGADZIE ALBERT K·Filed 2004·Application pending·0 cites
- 2743US7037921B2Compounds and methods for inhibiting MRP1LILLY CO ELI·Filed 2002·Granted May 2, 2006·0 cites·10 claims
- 2841US7101891B2Compounds and pharmaceutical compositions for inhibiting MRP1LILLY CO ELI·Filed 2002·Granted Sep 5, 2006·0 cites·2 claims
- 2938US7125840B2Substituted dipeptides as growth hormone secretagoguesLILLY CO ELI·Filed 2001·Granted Oct 24, 2006·0 cites·44 claims
- 3037US4826992A2,3-(Dihydro) bicyclic pyrazolidinonesLILLY CO ELI·Filed 1986·Granted May 2, 1989·1 cites·6 claims
- 3130US4826993ASubstituted diazolidinonesLILLY CO ELI·Filed 1986·Granted May 2, 1989·0 cites·8 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →